Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

The current situation in education and training of health-care professionals across Africa to optimise the delivery of palliative care for cancer patients.

Rawlinson F, Gwyther L, Kiyange F, Luyirika E, Meiring M, Downing J.

Ecancermedicalscience. 2014 Dec 11;8:492. doi: 10.3332/ecancer.2014.492. eCollection 2014. Review.

2.

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

Paton NI, Kityo C, Hoppe A, Reid A, Kambugu A, Lugemwa A, van Oosterhout JJ, Kiconco M, Siika A, Mwebaze R, Abwola M, Abongomera G, Mweemba A, Alima H, Atwongyeire D, Nyirenda R, Boles J, Thompson J, Tumukunde D, Chidziva E, Mambule I, Arribas JR, Easterbrook PJ, Hakim J, Walker AS, Mugyenyi P; EARNEST Trial Team.

N Engl J Med. 2014 Jul 17;371(3):234-47. doi: 10.1056/NEJMoa1311274.

3.

Collaboration across continents to produce e-learning for palliative care education in Sub Saharan Africa.

Rawlinson F, Luyirika E.

Ecancermedicalscience. 2014 May 27;8:ed36. doi: 10.3332/ecancer.2014.ed36. eCollection 2014. No abstract available.

4.

Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.

Fillekes Q, Kendall L, Kitaka S, Mugyenyi P, Musoke P, Ndigendawani M, Bwakura-Dangarembizi M, Gibb DM, Burger D, Walker AS; ARROW Trial Team.

Pediatr Infect Dis J. 2014 May;33(5):495-8. doi: 10.1097/INF.0000000000000143.

5.

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.

Jaganath D, Walker AS, Ssali F, Musiime V, Kiweewa F, Kityo C, Salata R, Mugyenyi P; DART Trial; ARROW Trial.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):523-30. doi: 10.1089/aid.2013.0255. Epub 2014 Feb 7.

PMID:
24506102
6.

Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI).

Cleary J, Powell RA, Munene G, Mwangi-Powell FN, Luyirika E, Kiyange F, Merriman A, Scholten W, Radbruch L, Torode J, Cherny NI.

Ann Oncol. 2013 Dec;24 Suppl 11:xi14-23. doi: 10.1093/annonc/mdt499.

7.

The net effect: spanning diseases, crossing borders-highlights from the fourth triennial APCA conference and annual HPCA conference for palliative care.

Downing J, Namisango E, Kiyange F, Luyirika E, Gwyther L, Enarson S, Kampi J, Sithole Z, Kemigisha-Ssali E, Masclee M, Mukasa I.

Ecancermedicalscience. 2013 Nov 5;7:371. doi: 10.3332/ecancer.2013.371. eCollection 2013.

8.

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.

Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb DM, Thiebaut R, Walker AS, Klein N, Callard R; ARROW Trial Team.

PLoS Med. 2013 Oct;10(10):e1001542. doi: 10.1371/journal.pmed.1001542. Epub 2013 Oct 29.

9.

Scaling up paediatric HIV care with an integrated, family-centred approach: an observational case study from Uganda.

Luyirika E, Towle MS, Achan J, Muhangi J, Senyimba C, Lule F, Muhe L.

PLoS One. 2013 Aug 6;8(8):e69548. doi: 10.1371/journal.pone.0069548. Print 2013.

10.

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

ARROW Trial team, Kekitiinwa A, Cook A, Nathoo K, Mugyenyi P, Nahirya-Ntege P, Bakeera-Kitaka S, Thomason M, Bwakura-Dangarembizi M, Musiime V, Munderi P, Naidoo-James B, Vhembo T, Tumusiime C, Katuramu R, Crawley J, Prendergast AJ, Musoke P, Walker AS, Gibb DM.

Lancet. 2013 Apr 20;381(9875):1391-403. doi: 10.1016/S0140-6736(12)62198-9. Epub 2013 Mar 7.

11.

Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe.

Musiime V, Cook A, Bakeera-Kitaka S, Vhembo T, Lutakome J, Keishanyu R, Prendergast AJ, Lubwama S, Robertson V, Hughes P, Nathoo K, Munderi P, Klein N, Musoke P, Gibb DM; ARROW Trial Team.

Pediatr Infect Dis J. 2013 Aug;32(8):856-62. doi: 10.1097/INF.0b013e31828c3991.

PMID:
23407100
12.

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.

Walker AS, Prendergast AJ, Mugyenyi P, Munderi P, Hakim J, Kekitiinwa A, Katabira E, Gilks CF, Kityo C, Nahirya-Ntege P, Nathoo K, Gibb DM; DART and ARROW trial teams.

Clin Infect Dis. 2012 Dec;55(12):1707-18. doi: 10.1093/cid/cis797. Epub 2012 Sep 12.

13.

Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa.

Nahirya-Ntege P, Cook A, Vhembo T, Opilo W, Namuddu R, Katuramu R, Tezikyabbiri J, Naidoo-James B, Gibb D; ARROW Trial Team.

PLoS One. 2012;7(5):e36186. doi: 10.1371/journal.pone.0036186. Epub 2012 May 2.

14.

A home-based approach to managing multi-drug resistant tuberculosis in Uganda: a case report.

Luyirika E, Nsobya H, Batamwita R, Busingye P, Musoke W, Nabiddo L, Karamagi Y, Mukasa B.

AIDS Res Ther. 2012 Apr 23;9(1):12. doi: 10.1186/1742-6405-9-12.

15.

Depression and its Relationship to Work Status and Income Among HIV Clients in Uganda.

Wagner GJ, Ghosh-Dastidar B, Dickens A, Nakasujja N, Okello E, Luyirika E, Musisi S.

World J AIDS. 2012;2(3):126-134.

16.

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.

Kasirye P, Kendall L, Adkison KK, Tumusiime C, Ssenyonga M, Bakeera-Kitaka S, Nahirya-Ntege P, Mhute T, Kekitiinwa A, Snowden W, Burger DM, Gibb DM, Walker AS; ARROW Trial Team.

Clin Pharmacol Ther. 2012 Feb;91(2):272-80. doi: 10.1038/clpt.2011.225. Epub 2011 Dec 21.

PMID:
22190066
17.

Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda.

Fillekes Q, Natukunda E, Balungi J, Kendall L, Bwakura-Dangarembizi M, Keishanyu R, Ferrier A, Lutakome J, Gibb DM, Burger DM, Walker AS; ARROW Trial Team.

J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):392-8. doi: 10.1097/QAI.0b013e318235e560.

PMID:
21926634
18.

Meeting the challenges of disability and HIV in East Africa.

Luyirika E, Kikule E, Kamba M, Buyondo F, Batamwita R, Featherstone A, Mills EJ.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):e68-9. doi: 10.1097/QAI.0b013e31821ac9a9. No abstract available.

PMID:
21860355
19.

Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.

Nahirya-Ntege P, Musiime V, Naidoo B, Bakeera-Kitaka S, Nathoo K, Munderi P, Mugyenyi P, Kekitiinwa A, Bwakura-Dangarembizi MF, Crawley J; ARROW Trial Team.

Pediatr Infect Dis J. 2011 Jun;30(6):535-7. doi: 10.1097/INF.0b013e3182076864.

PMID:
21164384
20.

Women, economic hardship and the path of survival: HIV/AIDS risk behavior among women receiving HIV/AIDS treatment in Uganda.

MacLachlan E, Neema S, Luyirika E, Ssali F, Juncker M, Rwabukwali C, Harvey M, Duncan T.

AIDS Care. 2009 Mar;21(3):355-67. doi: 10.1080/09540120802184121.

PMID:
19280411
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk